Back to results
US 10,501,456 B2Granted
Therapeutic agents for the treatment of HBV infection
AssigneeNewave Pharmaceutical Inc.
InventorsYi Chen, Yan Lou
Life of this patent
Estimating the term…
Abstract
The disclosure includes compounds of Formula (I) wherein Z1, Z2, Z3, X, R1, R2, R3, R4, R5, R6, and R7 are defined herein. Also disclosed is a method for treating HBV infection.
Claims7
A compound or an N-oxide thereof, or a pharmaceutically acceptable salt, stereoisomer, enantiomer, or tautomer thereof, wherein the compound is represented by Formula (A):
- wherein
- X is C(R0), in which R0 is H or D;
- Z1 is O;
- —Z2—R4 is halo or —O-alkyl;
- Z3 is O;
- R1 is alkyl, or cycloalkyl;
- each of R2, R3, and R6, is H;
- and
- R5 is H, alkyl, in which said alkyl is optionally substituted with alkoxy.
6 more elements
A compound, or an N-oxide thereof, or a pharmaceutically acceptable salt, stereoisomer, enantiomer, or tautomer thereof, wherein the compound is
A compound, or a pharmaceutically acceptable salt, an enantiomer, or a mixture thereof, wherein the compound is
Dependencies are inferred from the claim text.